Prove cliniche Nct
Clinical Trial Results:
A randomised, double blind, placebo controlled, multicentre phase III trial to evaluate the efficacy and safety of adding bevacizumab to gemcitabine and erlotinib in patients with metastatic pancreatic cancer
| Summary | |
EudraCT number | 2004-002854-78 |
Trial protocol | AT DE FI GB SE CZ ES IT |
Global completion date | 29 Feb 2008 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 30 Jan 2016 |
First version publication date | 30 Jan 2016 |
Other versions | |
Summary report(s) | CTg Receipt BO17706 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.